| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (N-Term), (Extracellular Domain) |
|---|
| Clone | polyclonal |
|---|
| Host Species | Rabbit |
|---|
| Reactive Species | human |
|---|
| Isotype | n/a |
|---|
| Format | immunogen affinity purified |
|---|
| Size | 100 µg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | CHRNA7 (Also known as Nicotinic Acetylcholine Receptor alpha 7) is a major component of brain nicotinic receptors that are blocked by alpha-bungarotoxin. The nicotinic acetylcholine receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. CHRNA7 has a signal peptide, followed by an N-terminal extracellular domain, 3 membrane-spanning regions, an intracellular domain, a fourth transmembrane region, and an extracellular C-terminal tail. The nicotinic acetylcholine receptor alpha-7 subunit is required for acetylcholine inhibition of macrophage TNF release. The nicotinic acetylcholine receptor alpha-7 subunit is essential for inhibiting cytokine synthesis by the cholinergic antiinflammatory pathway. Upregulation of CHRNA7 receptors may be a compensatory response to maintain basocortical cholinergic activity during disease progression or may act with beta-amyloid in disease pathogenesis. |
|---|
| Immunogen | KLH-coupled synthetic peptide from N-terminal extracellular domain of human CHRNA7. |
|---|
| Other Names | CHRNA7-2|NACHRA7|BTX|NARAD|nAChRa7|Acra7|alpha7 |
|---|
| Gene, Accession # | Gene ID: 1139 |
|---|
| Catalog # | ABIN2017586 |
|---|
| Price | |
|---|
| Order / More Info | Cholinergic Receptor, Nicotinic, alpha 7 (Neuronal) (CHRNA7) (N-Term), (Extracellular Domain) Antibody from ANTIBODIES-ONLINE GmbH |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|